ADAM10 and cancer: For example, the reduced activity of ADAM10 can result in the accumulation of unprocessed RTKs on the cell surface, thereby enhancing proliferative and survival signals that contribute to cancer progression and resistance to therapies, such as kinase inhibitors [68].